Continuing Education
Updates in Small Cell Lung Cancer
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1 hours
Related Topics: Small Cell Lung Cancer (SCLC), Lung Cancer, Bispecific Antibodies, Operational Challenges in Oncology Pharmacy
Description
The goal of this CE activity is to provide an overview of extensive stage small cell lung cancer. It aims to address strategies for preventing myelosuppression associated with etoposide- or topotecan- based chemotherapy. This CE activity will also provide clinical trial data and adverse event management of agents used in the relapsed and refractory setting including lurbinectedin and tarlatamab. Finally, it will discuss important clinical and operational considerations of bispecific T-cell engagers, enhancing participants’ understanding of these therapies.
Pricing
This activity does not require payment to register.
Login to Register for this Course
Register for the course and access course materials by logging into our learning management system.
This course has expired.
View our full list of NCODA courses or check the webinar recordings for more to discover.